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Abstract 
Purpose: To investigate the effect of 5,7-dimethoxycoumarin on inhibition of neuronal apoptosis in a rat 
model of acute cerebral infarction.  
Methods: Occlusion of middle cerebral artery was used for the preparation of a rat model of cerebral 
infarction. The rats in the treatment group were given 15 mg/kg dose of 5,7-dimethoxycoumarin daily for 
30 days intraperitoneally. However, those in the normal control and model groups received the same 
volume of normal saline. The rats were sacrificed after anaesthetization to extract brain samples.  
Results: Quantitative polymerase chain reaction (PCR) analysis showed a significant (p < 0.02) 
decrease in the level of caspase-3 mRNA by 5,7-dimethoxycoumarin compared to the model group. 
Western blot assay data revealed significant decrease in caspase-3 protein expression by 5,7-
dimethoxycoumarin. The higher activity of caspase-3 in acute cerebral infarction rats was reduced 
significantly (p < 0.005) following treatment with 15 mg/kg dose of 5,7-dimethoxycoumarin for 30 days. 
Treatment of the acute cerebral infarction rats with 15 mg/kg dose of 5,7-dimethoxycoumarin daily for 
30 days led to a greater decrease in apoptotic index than those of rats with model group (p < 0.005). 
5,7-Dimethoxycoumarin treatment daily for 30 days at a dose of 15 mg/kg also caused a significant (p < 
0.005) decrease in neurological impairment score compared to the model animal group.  
Conclusion: 5,7-Dimethoxycoumarin successfully inhibits neuronal apoptosis via inhibition of the 
expression of caspase-3 in brain tissues and thus may be useful for cerebral infarction therapy. 
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Acute cerebral infarction is a cerebrovascular 
disease and has very high incidence and 
mortality rate throughout the world [1,2]. The 
disease is characterized by blockage of blood to 
brain tissues leading to ischemia and hypoxia 
followed by necrosis of cerebral tissues [3]. The 
advanced stage of the disease involves 
generation of reactive oxygen radicals inducing 
neuronal cell death and subsequent activity 
impairment [4,5]. It is reported that during 
cerebral infarction in animals the rate of neuronal 
apoptosis is very high [6]. One of the important 
factors expressed in higher level and associated 
with the induction of neuronal apoptosis is the 
caspases [7-9]. In the brain tissue samples of 
cerebral infarction patients the expression of 
caspase-3 has been found to be markedly higher 
[10]. Thus inhibition of caspase-3 expression in 
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patients with cerebral infarction can play a vital 
role in the treatment of the disease. Therefore, 
various studies have been performed to 
investigate the effect of anti-oxidants on the 
pathology of cerebral infarction [11]. 
 
Coumarins, isolated in abundance from plant 
source exhibit promising anti-oxidant property 
[12, 13]. Both natural as well as synthetic 
coumarins are in clinical trials for the treatment of 
various types of cancers because of their 
tendency to induce carcinoma cell apoptosis [14]. 
5,7-Dimethoxycoumarin (Figure 1), a derivative 
of coumarin present in vegetables has shown 
potent anti-cancer activity through induction of 
DNA damage and inhibition of carcinoma cell 
proliferation [15,16]. The chemical structure of 
5,7-dimethoxycoumarinindicates that it has 
potential to act as anti-oxidant agent. 5,7-
dimethoxycoumarin also causes cell cycle arrest 
in melanoma cell lines resulting in inhibition of 
cell proliferation [17].The current study was 
designed and performed to investigate the effect 
of 5,7-dimethoxycoumarin on inhibition of 
apoptosis induction in the rat model of acute 
cerebral infarction. The study demonstrated that 
5,7-dimethoxycoumarin successfully inhibited 
neuronal apoptosis through targeting the 









Animals and ethical approval 
 
38-weeks old male Sprague-Dawley rats (~210 
g) used in the study were purchased using 
Animal licence: SCXK (no. Hebei 
2014/213/41/56) from the Experimental Animal 
Center of Hebei Medical University. Fifteen days 
before the start of actual experiment, the animals 
were acclimatized to the laboratory environment. 
All the rats were housed under 12 h light/dark 
cycle in groups of 2/cage. The room was 
maintained at a humidity of 50 – 60 % and 
temperature of 23 ± 1 oC. All the animals had 
free access to food and water. Approval for the 
study was taken from the Ethics Committee of 
the Xintai Municipal People's Hospital (approval 
no. CK43140407). All experimental animal 
procedures were conducted in compliance with 
State and Federal laws, standards of the US 
Department of Health and Human Services, and 
guidelines established by Tulane University 
Animal Care and Use Committee, accredited by 
Association for the Assessment and 
Accreditation of Laboratory Animal Care [18]. 
Efforts were made to reduce animal suffering to 
the minimum possible. 
 
Preparation of animal model of acute cerebral 
infarction 
 
For the preparation of acute cerebral infarction, a 
rat model cerebral artery infarction method 
reported earlier was used [19]. The 
establishment of animal model was confirmed by 
carefully examining the rats after surgery. The 
rats were then divided into three groups of 10 
each; normal control, model and the treatment 
groups. The rats in the treatment group were 
injected 15 mg/kg doses of 5,7-
dimethoxycoumarin daily for 30 days whereas 
those in the model and normal control group 




Total RNA from the brain tissue samples was 
isolated using TRIzol (Invitrogen, Carlsbad, CA, 
USA) as per the instructions mentioned in the 
manual protocol. The extracted RNA (1 μg) 
samples were subjected to reverse transcription 
using M-MLV reverse transcriptase and the 
Random-pdN6 Primer (Invitrogen). Amplification 
of the signals was performed using polymerase 
chain reaction (PCR) as follows: in the 50 μL 
water was taken template cDNA (2 μL), dNTPs 
(0.2 mM), 1.25 U/μL Go Taq polymerase 
(Promega, Madison, WI, USA) along with the 
various primers (0.5 μM each). It was then 
denatured by heating at 95 ˚C for 30 s and 
subsequently annealed for 30 sec at melting 
temperature. Elongation over 30 cycles was 
performed at 72 ˚C for 1-min. The sequence of 
used caspase-3 primer was: forward, 5'-GGT 
ATT GAG ACA GAC AGT GG-3' and reverse, 5'-
CAT  GGG ATC TGT TTC TTT GC-3'. 
Electrophoresis of the PCR products was 
performed on 2.0 % agarose gel and 
photographed under UV. 
 
Western blot analysis 
 
The brain tumor samples from the rats were 
collected, washed with cold PBS and 
subsequently treated with lysis buffer. After 
treatment with ice-cold lysis buffer for 45 min, the 
lysates were subjected to centrifugation for 15 
min at 4 oC at 12,000 x g. The supernatant was 
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then collected and the concentration of proteins 
in the samples was analysed using Bicinchoninic 
Acid Protein Assay kit (Pierce, Rockford, IL, 
USA). The 50 µg protein samples were subjected 
to electrophoresis over 12 % sodium dodecyl 
sulphate-polyacrylamide gel. The protein 
samples were transferred to polyvinylidene 
difluoride (PVDF) membranes using a semidry 
transfer system (Bio-Rad Laboratories, Hercules, 
CA, USA). The non-specific sites in the 
membranes were incubated with 5 % bovine 
serum albumin and Tris-buffered saline with 
Tween® 20 buffer for 3 h. The bands were 
incubated with a specific rabbit anti-human 
antibody against caspase-3 mRNA (Cell 
Signaling Technology, Beverly, MA, USA). The 
bands were normalized to β-actin concentration. 
The complex development was performed using 
an ECL detection kit as per the manufacturer's 
instructions (ECL GST western blotting detection 
kit, Pierce Biotechnology, Inc., Waltham, MA, 
USA). For the purpose of imaging, GelGDoc2000 
imaging system (Bio-Rad Laboratories GmbH, 
Munich, Germany) was employed.  
 
Examination of neurological impairment 
 
Analysis of the impairment in neurological activity 
was performed using the known scale developed 
by Bederson [20]. The score of neurological 
impairment after surgery on the scale was 
assigned as follows: No neurological impairment 
symptoms = 0 score; problem in front paw 
extension = 1 score; rolling of body to left side = 
2; tilting to one side only = 3 and complete 
movement loss = 4. 
 
Analysis of caspase‑3 activity 
 
The activity of caspase-3 was analysed using 
commercially available reagent for detection of 
caspase-3 protein action (Beyotime Institute of 
Biotechnology, Beijing, China).  
 
Terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) assay 
 
Brain tissue sample apoptosis was analysed 
using the In Situ Cell Death Detection kit, POD 
(Roche). The brain tissue samples were 
embedded in paraffin after washing with PBS 
and cut into thin 2 µm sections. The sections 
were then de-parrafined in boiling xylene and 
treated with hydrogen peroxide. The sections 
were fixed with 4 % paraformaldehyde and then 
subjected to counter staining for 10 min with 4',6-
diamidino-2-phenylindole under dark 
atmosphere. The sections were observed 
carefully for apoptotic cells (TUNEL-positive 
cells) under a fluorescence microscope 





SPSS software, version 17.0 (SPSS, Inc., 
Chicago, IL, USA) was employed for the analysis 
of the data. The data are presented as mean ± 
standard deviation (n = 3). The variance analysis 
was used for the comparison of the data among 
the groups. The differences were taken as 




Effect of 5,7-dimethoxycoumarin on caspase-
3 mRNA levels  
 
Quantitative PCR analysis showed a significantly 
(p < 0.05) higher level of caspase-3 mRNA in the 
rats with acute cerebral infarction compared to 
the normal control group (Figure 2). Treatment of 
the rats with 5,7-dimethoxycoumarin caused a 
significant (p < 0.02) reduction in the level of 
caspase-3 mRNA than those in the model group 
(Figure 2). Analysis of the caspase-3 protein 
level in rats of the model group revealed 
significantly higher level than those of the normal 
control rats (Figure 2). 5,7-Dimethoxycoumarin 
treatment of the rats with acute cerebral 
infarction caused a significant decrease in the 
level of caspase-3 protein compared to the 
model animal group (Figure 2). The level of both 
mRNA and protein corresponding to caspase-3 
was thus reduced in the rats with acute cerebral 
infarction on treatment with 15 mg/kg dose of 
5,7-dimethoxycoumarin. 
 
Effect of 5,7-dimethoxycoumarin on 
caspase‑3 activity  
 
Analysis of the activity of caspase-3 in the rats 
with acute cerebral infarction revealed 
significantly (p < 0.05) higher level than those of 
rats in the normal control group. The higher 
activity of caspase-3 in acute cerebral infarction 
rats was reduced significantly on treatment with 
15 mg/kg dose of 5,7-dimethoxycoumarin for 30 
days. Caspase-3 activity in the normal, control 
and treatment groups was 2, 15 and 3.6, 
respectively. On the day 30th of treatment, level 
of caspase-3 activity in the normal control and 
5,7-dimethoxycoumarin treatment groups was 
found to be similar. 
 
Effect of 5,7-dimethoxycoumarin on apoptotic 
index and infarction scope  
 
The apoptotic index in rats with acute cerebral 
infarction was markedly higher compared to  
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Figure 2: 5,7-dimethoxycoumarinprevents increase in expression level of mRNA and protein corresponding to 
caspase‑3 in the rats with acute cerebral infarction. Rats with acute cerebral infarction were treated for 30 days 
with 15 mg/kg dose of 5,7-dimethoxycoumarin daily. The expression level of caspase‑3 mRNA and proteins in 
the rat brain samples was analysed using qPCR and western blot assay, respectively 
 
normal control (Figure 3). However, treatment of 
the acute cerebral infarction rats with 15 mg/kg 
dose of 5,7-dimethoxycoumarin daily for 30 days 
led to a significant decrease in apoptotic index 
than those of rats in the model group (Figure 3). 
 
Effect of 5,7-dimethoxycoumarin on 
neurological impairment in rats with acute 
cerebral infarction 
 
In the rats with acute cerebral infarction, 
neurological impairment was found to be 
markedly higher compared to the normal control 
group (Figure 4). 5,7-dimethoxycoumarin 
treatment daily for 30 days at a dose of 15 mg/kg 
caused a significant decrease in the neurological 





Coumarins, natural phytochemical products 
obtained from plants possess promising anti-
oxidant activity [12,13]. Many coumarin 
molecules are in clinical trials against various 
types of diseases including carcinoma [14]. 
Apoptosis, programmed death of cells is induced 
through the generation of reactive oxygen 
species in cells which damage DNA and affect 
cellular pathways. In brain tissue samples of rats 
and patients the rate of neuronal apoptosis has 
been found to be markedly high [21]. Therefore, 
in the current study effect of the anti-oxidant, 5,7-
dimethoxycoumarin on prevention of apoptosis 
induction in neuronal cells of acute cerebral 
infarction rats was investigated. The main factor 
responsible for induction of cell apoptosis is a 
protease, caspase-3 which triggers cellular 
pathways involved in neuronal apoptosis [22]. In 
the current study, the expression of both mRNA 
and protein corresponding to caspase-3 in the 
brain samples of rats with acute cerebral 
infarction was markedly higher. However, 5,7-
dimethoxycoumarin prevented the increase in the 
level of mRNA and protein corresponding to 
caspase-3 in the rats.  
 
The higher activity of caspase-3 in acute cerebral 
infarction rats was reduced significantly on 
treatment with 5,7-dimethoxycoumarin for 30 
days. Caspase-3 is considered to be the 
significant target for prevention of acute cerebral 
infarction because of its major role in ischemia 
and induction of apoptosis [23,24]. In the current  
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Figure 3: 5,7-Dimethoxycoumarin prevents increase in apoptosis index in the rats with acute cerebral infarction. 
The brain samples of rats with acute cerebral infarction after treatment with 5,7-dimethoxycoumarin were 
analysed for apoptotic index using TUNEL staining. Quantification of neuronal cell apoptosis was performed 




Figure 4: 5,7-Dimethoxycoumarin prevents the increase in  neurological impairment score in rats with acute 
cerebral infarction. The rats in the treatment group were injected with 15 mg/kg dose of 5,7-dimethoxycoumarin 
daily for 30 days and then neurological impairment score was examined. 
 
study, the apoptotic index of rats with acute 
cerebral infarction was markedly higher than for 
normal control. However, treatment of the acute 
cerebral infarction rats with 5,7-
dimethoxycoumarin daily for 30 days led to a 
significant decrease in the apoptotic index than 
those of rats in the model group. In the rats with 
acute cerebral infarction, neurological impairment 
was markedly higher compared to the normal 
control group. 5,7-Dimethoxycoumarin treatment 
daily for 30 days caused a significant decrease in 
the neurological impairment score compared to 




The findings of the present study demonstrate 
that 5,7-dimethoxycoumarin successfully inhibits 
neuronal apoptosis by inhibition of expression of 
caspase-3 in brain tissues. Therefore, 5,7-
dimethoxycoumarin can potentially be used for 
the treatment of acute cerebral infarction in 
patients. 
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